Royal Bank of Canada’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60K Sell
2,401
-2,148
-47% -$55.6K ﹤0.01% 5395
2025
Q4
$116K Buy
4,549
+780
+21% +$17.4K ﹤0.01% 5120
2025
Q3
$61K Buy
3,769
+206
+6% +$3.33K ﹤0.01% 5737
2025
Q2
$57K Sell
3,563
-18
-0.5% -$272 ﹤0.01% 5867
2025
Q1
$61K Sell
3,581
-1,038
-22% -$21.7K ﹤0.01% 5491
2024
Q4
$114K Sell
4,619
-5,064
-52% -$144K ﹤0.01% 5256
2024
Q3
$276K Sell
9,683
-10,659
-52% -$314K ﹤0.01% 4567
2024
Q2
$537K Buy
20,342
+1,845
+10% +$52.5K ﹤0.01% 3957
2024
Q1
$597K Sell
18,497
-21,239
-53% -$775K ﹤0.01% 3842
2023
Q4
$1.67M Sell
39,736
-305
-0.8% -$11.2K ﹤0.01% 3218
2023
Q3
$1.54M Buy
40,041
+35,692
+821% +$807K ﹤0.01% 3085
2023
Q2
$83K Buy
4,349
+470
+12% +$8.77K ﹤0.01% 5468
2023
Q1
$60K Sell
3,879
-2,297
-37% -$39.9K ﹤0.01% 5525
2022
Q4
$109K Buy
6,176
+4,635
+301% +$58.4K ﹤0.01% 5385
2022
Q3
$9K Buy
1,541
+275
+22% +$1.34K ﹤0.01% 6476
2022
Q2
$5K Sell
1,266
-2,267
-64% -$9.79K ﹤0.01% 6646
2022
Q1
$20K Sell
3,533
-5,093
-59% -$31.7K ﹤0.01% 6604
2021
Q4
$74K Buy
8,626
+4,228
+96% +$34.9K ﹤0.01% 6140
2021
Q3
$38K Buy
4,398
+1,289
+41% +$11.6K ﹤0.01% 6322
2021
Q2
$33K Buy
3,109
+758
+32% +$10.6K ﹤0.01% 6292
2021
Q1
$38K Buy
2,351
+316
+16% +$8.33K ﹤0.01% 6058
2020
Q4
$94K Buy
2,035
+344
+20% +$15.9K ﹤0.01% 5374
2020
Q3
$60K Buy
1,691
+1,649
+3,926% +$49.6K ﹤0.01% 5266
2020
Q2
$1K Buy
+42
New +$900 ﹤0.01% 6432

Other funds holding IMVT